Guerbet SA (EPA:GBT)

France flag France · Delayed Price · Currency is EUR
20.25
-1.95 (-8.78%)
Mar 28, 2025, 5:35 PM CET
-39.64%
Market Cap 255.33M
Revenue (ttm) 840.79M
Net Income (ttm) 32.76M
Shares Out 12.61M
EPS (ttm) 2.60
PE Ratio 7.79
Forward PE 9.11
Dividend 0.50 (2.47%)
Ex-Dividend Date Jul 1, 2024
Volume 94,031
Average Volume 21,955
Open 22.00
Previous Close 22.20
Day's Range 19.96 - 22.00
52-Week Range 19.80 - 40.25
Beta 0.80
RSI 22.71
Earnings Date Mar 26, 2025

About Guerbet

Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1926
Employees 2,920
Stock Exchange Euronext Paris
Ticker Symbol GBT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.